
XSNX
Healthcare · Biotechnology · $6,165 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 31, 2024 | Time not confirmed | — | -0.02 | — |
| May 15, 2024 | Before the open | — | -0.02 | — |
| Feb 27, 2024 | After the close | — | 0.01 | — |
| Aug 11, 2023 | After the close | — | -0.04 | — |
| May 15, 2023 | After the close | — | 0.01 | — |
| Feb 14, 2023 | Before the open | 0.00 | -0.14 | — |
| Aug 15, 2022 | After the close | — | -0.02 | — |
| May 16, 2022 | Before the open | — | -0.08 | — |
| Jan 13, 2022 | Time not confirmed | — | 0.01 | — |
| Aug 13, 2021 | Time not confirmed | — | -0.16 | — |
| May 6, 2021 | Time not confirmed | — | 0.02 | — |
| Mar 30, 2021 | Time not confirmed | — | -4.61 | — |
| Aug 21, 2020 | Time not confirmed | — | 0.13 | — |
| May 14, 2020 |
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
| Time not confirmed |
| — |
| -0.22 |
| — |
| Jan 24, 2020 | Time not confirmed | — | 0.01 | — |
| Dec 20, 2019 | Time not confirmed | — | 0.06 | — |
| Aug 19, 2019 | Time not confirmed | — | 0.07 | — |
| May 14, 2019 | Time not confirmed | — | -0.35 | — |
| Jan 7, 2019 | Time not confirmed | — | 0.09 | — |
| Dec 31, 2018 | Time not confirmed | — | 0.25 | — |
| Aug 14, 2018 | Time not confirmed | — | 1.94 | — |
| May 21, 2018 | Time not confirmed | — | -4.46 | — |
| Feb 12, 2018 | Time not confirmed | — | -0.33 | — |